Inventor · disambiguated record
Hendrik Gille
Also filed as: GILLE HENDRIK
6 granted patents·5 pending applications·43 citations·filing 2001–2019
80Inventor score
Top patents by PatentIndex Score
11 records- 0192US10526382B2Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereofPIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Jan 7, 2020·6 cites·47 claims
- 0290US9051382B2Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding suchTRENTMANN STEFAN·Filed 2011·Granted Jun 9, 2015·26 cites·13 claims
- 0382US9950034B2Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulationPIERIS PHARMACEUTICALS GMBH·Filed 2017·Granted Apr 24, 2018·3 cites·20 claims
- 0482US9610356B2Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulationPIERIS PHARMACEUTICALS GMBH·Filed 2012·Granted Apr 4, 2017·7 cites·23 claims
- 0563US11034738B2Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)PIERIS PHARMACEUTICALS GMBH·Filed 2019·Granted Jun 15, 2021·0 cites·18 claims
- 0662US10064963B2Methods and compositions for treating disordersPIERIS AG·Filed 2013·Granted Sep 4, 2018·1 cites·8 claims
- 0755US2018311311A1Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulationPIERIS PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 0852US2017369542A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 0946US2015291675A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS AG·Filed 2015·Application pending·0 cites
- 1042US2004088746A1Apoptosis-inducing dna sequencesFiled 2001·Application pending·0 cites
- 1130US2012201873A1Controlled release formulations of lipocalin muteinsHOHLBAUM ANDREAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hendrik Gille files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →